Skip to main content

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Misoprostol for Bloating and Distension

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Misoprostol for Bloating and Distension

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

PerQseal® Impella Early Feasibility Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about PerQseal® Impella Early Feasibility Study

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.

A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors

Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 188
  • Page 189
  • Page 190
  • Page 191
  • Page 192
  • Page 193
  • Page 194
  • Page 195
  • Page 196
  • …
  • Next page Next
  • Last page Last
Subscribe to